VX-150

VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.


Cat. No.: EX-A5013	Purity: >98%

	Chemical structure of VX-150

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	400	In-stock
50mg	500	In-stock
100mg	650	In-stock
250mg	900	In-stock
500mg	1200	In-stock
1g	1750	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1793080-72-4
Purity	>98%
Formula	C21H17F4N2O7P
Mol Weight	516.3363
Color	White to off-white
State	solid powder
Solubility	Soluble in DMSO 125 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Hemme J Hijma, et al. A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults. Pain Med. 2021 Aug 6;22(8):1814-1826.
CoA	CoA of VX-150


		Search